7 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Build a regimen using ... are contacts of infectious ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Cold Urticaria
Prevalence - 0.05% in the population
Disease onset - Mostly 2nd to 4th decades of life
Causes
and clinical associations ... Infections 2. ... Drugs 5. ... #rheumatology #comparison ... #table
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... HIV-infected persons with clinical ... Please refer to the table ... Guidelines for dosing ... #HIVAIDS #pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Clinically Significant ... Cardiovascular Drug-Drug ... vera, Licorice - Causes ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Differentiating NBTE from Infective Endocarditis
No pathognomonic signs/symptoms or echo features that are specific to NBTE, and
of intravenous drug ... in up to 30% of cases ... large infarct - Infectious ... #Endocarditis #comparison ... Marantic #diagnosis #table
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
disease based on clinical ... please refer to Table ... 5 for dosing recommendation ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... histoplasmosis (>10 cases ... weeks or until clinically ... with ARV (see Table ... #HIVAIDS #pharmacology